Cytoglobin: Key player in preventing liver disease

Cytoglobin: Key player in preventing liver disease

Researchers have discovered that the use of Cytoglobin (CYGB) as an intravenous drug could delay liver fibrosis progression in mice.

Comments are closed.

Women have a lower range of ‘normal’ blood pressure than men
16 February 2021
Delayed medical treatment of high-impact injuries: A lesson from the Syrian civil war
16 February 2021